Welcure Drugs and Pharmaceuticals Limited (BOM:524661)
India flag India · Delayed Price · Currency is INR
0.2900
-0.0100 (-3.33%)
At close: Mar 6, 2026

BOM:524661 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Net Income
21.7-1.751.020.240.55
Depreciation & Amortization
0.080.36---
Other Operating Activities
6.1-00--
Change in Accounts Receivable
-189.5----
Change in Inventory
-1,435----
Change in Accounts Payable
28.98----
Change in Other Net Operating Assets
-652.410.110.05-0.05-0.13
Operating Cash Flow
-2,220-1.281.070.190.42
Operating Cash Flow Growth
--476.20%-56.02%-
Capital Expenditures
-0.17----
Investment in Securities
-1.65---
Other Investing Activities
-0.47----
Investing Cash Flow
-0.641.65---
Long-Term Debt Issued
1,232----
Long-Term Debt Repaid
--0.17-14.92--
Net Debt Issued (Repaid)
1,232-0.17-14.92--
Issuance of Common Stock
990-13.21--
Financing Cash Flow
2,222-0.17-1.72--
Miscellaneous Cash Flow Adjustments
00---
Net Cash Flow
1.070.2-0.650.190.42
Free Cash Flow
-2,220-1.281.070.190.42
Free Cash Flow Growth
--476.20%-56.02%-
Free Cash Flow Margin
-904.46%--17.67%31.64%
Free Cash Flow Per Share
-2.59-0.010.010.000.00
Levered Free Cash Flow
-1,3901.010.310.150.47
Unlevered Free Cash Flow
-1,3901.010.310.150.47
Change in Working Capital
-2,2480.110.05-0.05-0.13
Source: S&P Global Market Intelligence. Standard template. Financial Sources.